SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001019687-14-000487
Filing Date
2014-02-12
Accepted
2014-02-12 17:22:40
Documents
7
Period of Report
2014-02-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K peregrine_8k.htm 8-K 36230
2 UNDERWRITING AGREEMENT peregrine_8k-0101.htm EX-1.1 198279
3 OPINION peregrine_ex0501.htm EX-5.1 6844
4 GRAPHIC image_001.jpg GRAPHIC 5228
5 TAX OPINION peregrine_ex0801.htm EX-8.1 6067
6 PRESS RELEASE peregrine_ex9901.htm EX-99.1 8823
7 GRAPHIC image_002.jpg GRAPHIC 3069
  Complete submission text file 0001019687-14-000487.txt   269440
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-32839 | Film No.: 14601509
SIC: 2834 Pharmaceutical Preparations